Article
Pfizer's diabetes drug results in similar weight loss levels as Novo's Ozempic
Rating:
0.0
Views:
38
Likes:
1
Library:
1
Pfizer Inc's diabetes drug resulted in weight loss similar to that of Novo Nordisk's Ozempic in a mid-stage study testing it in patients with type 2 diabetes, according to data published in a medical journal.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value